Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Gazprom Neft will study the underlying horizons of the Verkhnesalymsky block

1/10/24 SIBN

Sistema became the owner of La Datcha guest complex

1/10/24 AFKS

Fix Price plans to open at least 750 stores

1/9/24 FIXP

Fesco air delivery service transported 4 times more groupage cargoes

1/9/24 FESH

PIK lost its leadership in terms of current construction volumes

1/9/24 PIKK

Samolet' has become the new leader of the construction market

1/9/24 SMLT

NLMK shareholders appointed Sergey Karatayev as President of the Company

1/9/24 NLMK

Shareholders of Donskoy Factory of Radiocomponents approved dividends

1/9/24 DZRD

Tinkoff Bank received a FPI license in India

1/9/24 T

TCS Group shareholders' meeting on redomiciliation postponed for a week

1/9/24 T